We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$292K
Cap. Flow %
-0.2%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$30.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.96M
3
GM icon
General Motors
GM
+$484K
4
DSKEW
Daseke, Inc. Warrant
DSKEW
+$417K
5
TSLA icon
Tesla
TSLA
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 8.73%
2 Financials 6.69%
3 Consumer Discretionary 5.75%
4 Industrials 4.37%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHK
201
DELISTED
Chesapeake Energy Corporation
CHK
$75K 0.05%
94
-271
-74% -$211K
OII icon
202
Oceaneering
OII
$4.79B
$73K 0.05%
+3,451
New +$73.4K
NFLX icon
203
PUT
Netflix
NFLX
$287B
$70K 0.05%
49,000
– –
DLB icon
204
Dolby
DLB
$4.65B
$69K 0.05%
1,110
+882
+387% +$53.3K
EL icon
205
Estee Lauder
EL
$28.9B
$62K 0.04%
490
+294
+150% +$35.3K
THO icon
206
Thor Industries
THO
$3.9B
$60K 0.04%
+400
New +$55.6K
NEM icon
207
Newmont
NEM
$101B
$57K 0.04%
1,521
+114
+8% +$4.19K
TFSL icon
208
TFS Financial
TFSL
$5.09B
$48K 0.03%
3,212
+2,977
+1,267% +$45.8K
GT icon
209
CALL
Goodyear
GT
$2.02B
$39K 0.03%
10,000
– –
PPLI
210
People Inc
PPLI
$3.14B
$34K 0.02%
+1,539
New +$34.5K
OPK icon
211
Opko Health
OPK
$883M
$27K 0.02%
5,513
-22,910
-81% -$133K
ASH icon
212
Ashland
ASH
$3.05B
$25K 0.02%
+354
New +$24.4K
CRM icon
213
Salesforce
CRM
$129B
$25K 0.02%
243
+108
+80% +$11K
HOG icon
214
Harley-Davidson
HOG
$2.79B
$25K 0.02%
+487
New +$23.7K
LECO icon
215
Lincoln Electric
LECO
$13.7B
$25K 0.02%
271
-2,911
-91% -$266K
PNC icon
216
PNC Financial Services
PNC
$99.5B
$25K 0.02%
172
+166
+2,767% +$22.9K
SHW icon
217
Sherwin-Williams
SHW
$76.6B
$25K 0.02%
+183
New +$24.1K
SYY icon
218
Sysco
SYY
$39.1B
$25K 0.02%
410
+210
+105% +$11.9K
SGI
219
Somnigroup International
SGI
$14.5B
$25K 0.02%
+1,584
New +$24.2K
STI
220
DELISTED
SunTrust Banks, Inc.
STI
$25K 0.02%
385
+90
+31% +$5.5K
LLL
221
DELISTED
L3 Technologies, Inc.
LLL
$25K 0.02%
+126
New +$24K
USG
222
DELISTED
Usg
USG
$25K 0.02%
644
-8,054
-93% -$283K
CAVM
223
DELISTED
Cavium, Inc.
CAVM
$25K 0.02%
+296
New +$22.9K
BSX icon
224
Boston Scientific
BSX
$64.8B
$24K 0.02%
960
+902
+1,555% +$24.9K
EPC icon
225
Edgewell Personal Care
EPC
$1.23B
$24K 0.02%
404
+169
+72% +$10.6K
7 8
9
10 11

Similar funds

LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return
SPCP
Snow Park Capital Partners New York $3.17M AUM 3.35% 1-Year Est. Return
GZ
George Zachary $2.34M AUM 5.28% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
DAL
David A. Lorber $1.11M AUM 4.74% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group's Q4 2017 filing shows 229 new, 159 increased, 207 reduced and 182 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,800 shares worth $512K. The largest sale was Aimmune Therapeutics, an estimated $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, up from 4.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke, Inc. Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.